Understanding how certain molecules can enhance glutamate transport in the brain
The mechanism of allosteric modulation of glutamate transporters
This study is looking at how certain small molecules can help improve the function of a brain protein that keeps glutamate levels balanced, which could help protect against damage in conditions like Alzheimer's or Parkinson's disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Drexel University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10764903 on NIH RePORTER |
What this research studies
This research investigates how specific small molecules can modulate the activity of glutamate transporters, which are crucial for maintaining healthy levels of glutamate in the brain. By focusing on the glial glutamate transporter EAAT2, the study aims to uncover the molecular mechanisms that allow these compounds to enhance glutamate clearance, potentially preventing neuronal damage associated with neurodegenerative diseases. The research employs a combination of functional studies, structural analysis, and computational modeling to explore the interactions between the transporters and the allosteric modulators.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from neurodegenerative diseases, particularly those with conditions linked to glutamate toxicity, such as epilepsy.
Not a fit: Patients with non-neurodegenerative conditions or those not affected by glutamate dysregulation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for neurodegenerative diseases by improving glutamate clearance and reducing excitotoxicity.
How similar studies have performed: Previous research has shown promise in targeting glutamate transporters for therapeutic purposes, indicating that this approach may lead to significant advancements in treatment.
Where this research is happening
Philadelphia, United States
- Drexel University — Philadelphia, United States (Active)
Researchers
- Principal investigator: Mortensen, Andreia C K — Drexel University
- Study coordinator: Mortensen, Andreia C K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.